In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Justin Honaman, Amazon Web Services, Part 2
The era of agentic commerce gets underway.
Video Forum: Justin Honaman, Amazon Web Services, Part 1
New technologies promise to transform retail, CPG sectors.
Video Forum: Dave Warner, KPH Healthcare Services
Kinney Drugs parent finds strength in diversification.
Latest
TYLENOL partners with fitness instructor Cody Rigsby
Rigsby is sharing how he manages his post-workout aches and pains with TYLENOL Extra Strength Liquid Gels on Instagram.
Walgreens trials body-worn cameras for store employees
Walgreens stated that the initiative aims to help lower tensions in tough situations and prevent disruptive behavior.
Kearney unveils Women’s Health Healthcare and Life Sciences Index
New report tracks how gender-responsive practices that improve the health of women are embedded across pharma, MedTech, consumer health, payor, provider, and investor value chains.
Circana launches AI-driven 'Complete Why' solution for CPG sales insights
The Complete Why solution uses store- and week-level models to diagnose and measure the effects of up to 60 different drivers per product and market.